Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor -/- mice

Annals of the New York Academy of Sciences

Volumn 892, Issue , 1999, Pages 108-118

  Daugherty, Alan ^a   Cassis, Lisa ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b University of Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; CHOLESTEROL; CHOLIC ACID; LOW DENSITY LIPOPROTEIN RECEPTOR; SATURATED FATTY ACID; TRIACYLGLYCEROL;

ABDOMINAL AORTA; ABDOMINAL AORTA ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ARCH; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; FAT INTAKE; MOUSE; NONHUMAN; SYSTOLIC BLOOD PRESSURE; THORACIC AORTA; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032787345     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07789.x     Document Type: Conference Paper

References (21)

1. 1. Pfeffer, M. A., E. Braunwald, L. A. Moye, F. Basta, E. J. Brown, T. E. Cuddy, B. R. Davis, E. M. Geltman, S. Goldman, G. C. Flaker, M. Klein, G. A. Lamas, M. Packer, J. Rouleau, J. L. Rouleau, J. Rutherford, J. H. Wertheimer & C. M. Hawkins. 1992. Effect of captropril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 327: 669-677.
2. 2. Aberg, G. & P. Ferrer. 1990. Effects of captopril on atherosclerosis in cynomolgus monkeys. J. Cardiovasc. Pharmacol. 15: S65-S72.
3. 3. Charpiot, P., P. H. Rolland, A. Friggi, P. Piquet, E. Scalbert, H. Bodard, A. Barlatier, V. Latrille, P. Tranier, C. Mercier, R. Luccioni, R. Calaf & D. Garcon. 1993. ACE Inhibition with perindopril and atherogenesis-induced structural and functional changes in minipig arteries. Arteriosclerosis and Thrombosis 13: 1125-1138.
4. 4. Chobanian, A. V., C. C. Haudenschild, C. Nickerson & R. Drago. 1990. Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension 15: 327-331.
5. 5. Kowala, M. C., R. I. Grove & G. Aberg. 1994. Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Fosinopril reduces plasma cholesterol and captopril inhibits macrophage-foam cell accumulation independently of blood pressure and plasma lipids. Atherosclerosis 108: 61-72.
6. 6. Keidar, S., J. Attias, J. Smith, J. L. Breslow & T. Hayek. 1997. The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice. Biochem. Biophys. Res. Commun. 236: 622-625.
7. 7. Hayek, T., J. Attias, J. Smith, J. L. Breslow & S. Keidar. 1998. Antiatherosclerotic and antioxidative effects of captopril in apolipoprotein E-deficient mice. J. Cardiovasc. Pharmacol. 31: 540-544.
8. 8. Cheng, J. W., & M. N. Ngo. 1997. Current perspective on the use of angiotensin-converting enzyme inhibitors in the management of coronary (atherosclerotic) artery disease. Ann. Pharmacother. 31: 1499-1506.
9. 9. Keidar, S. 1998. Angiotensin, LDL peroxidation and atherosclerosis. Life Sci. 63: 1-11.
10. 10. Scheidegger, K. J., S. Butler & J. L. Witztum. 1997. Angiotensin II increases macrophage-mediated modification of low density lipoprotein via a lipoxygenase-dependent pathway. J. Biol. Chem. 272: 21609-21615.
11. 11. Chen, X. L., P. E. Tummala, M. T. Olbrych, R. W. Alexander & R. M. Medford. 1998. Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ. Res. 83: 952-959.
12. 12. Ishibashi, S., J. L. Goldstein, M. S. Brown, J. Herz & D. K. Burns. 1994. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J. Clin. Invest. 93: 1885-1893.
13. 13. Roselaar, S. E., P. X. Kakkanathu & A. Daugherty. 1996. Lymphocyte populations in atherosclerotic lesions of ApoE -/-and LDL receptor -/-mice - Decreasing density with disease progression. Arterioscler. Thromb. Vasc. Biol. 16: 1013-1018.
14. 14. Daugherty, A., E. Pure, D. Delfel-Butteiger, S. Chen, J. Leferovich, S. E. Roselaar & D. J. Rader. 1997. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E -/-mice. J. Clin. Invest. 100: 1575-1580.
15. 15. Nickerson, C. J., C. C. Haudenschild & A. V. Chobanian. 1992. Effects of hypertension and hyperlipidemia on the myocardium and coronary vasculature of the WHHL rabbit. Exp. Mol. Pathol. 56: 173-185.
16. 16. Overturf, M. L., C. Aschenbrener, R. E. Druilhet & W. M. Kirkendall. 1981. Renin as a risk factor for atherogenesis. Effects of hypercholesterolemia and two-kidney - one-clip hypertension in the rabbit. Atherosclerosis 38: 97-119.
17. 17. Sugiyama, F., S. Haraoka, T. Watanabe, N. Shiota, K. Taniguchi, Y. Ueno, K. Tanimoto, K. Murakami, A. Fukamizu & K. Yagami. 1997. Acceleration of atherosclerotic lesions in transgenic mice with hypertension by the activated renin-angiotensin system. Lab. Invest. 76: 835-842.
18. 18. Boring, L., J. Gosling, M. Cleary & I. F. Charo. 1998. Decreased lesion formation in CCR2(-/-) mice reveals a role for chemokines in the inhibition of atherosclerosis. Nature 394: 894-897.
19. 19. Gu, L., Y. Okada, S. K. Clinton, C. Gerard, G. K. Sukhova, P. Libby & B. J. Rollins. 1998. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell 2: 275-281.
20. 20. Tangirala, R. K., E. M. Rubin & W. Palinski. 1995. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J. Lipid Res. 36: 2320-2328.
21. 21. Carmeliet, P., L. Moons, R. Lijnen, M. Baes, V. Lemaitre, P. Tipping, A. Drew, Y. Eeckhout, S. Shapiro, F. Lupu & D. Collen. 1997. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nature Genet. 17: 439-444.